PLSE · Pulse Biosciences, Inc. · Proposed Sales
$49.30
-0.45 (-0.90%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$3.68B
Shares
71.32M
Volume · Oct 7
52.64K
Avg daily vol (3M)
500.06K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-02-12 | KEVIN DANAHY | Officer | 50,000 | 2026-02-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-09 | KEVIN DANAHY | Officer | 75,000 | 2026-02-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-18 | KEVIN DANAHY | Officer | 25,000 | 2025-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-11 | DARRIN UECKER | Director, Officer | 120,000 | 2025-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-06-13 | DARRIN UECKER | Officer, Director | 15,000 | 2025-06-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-06-12 | DARRIN UECKER | Officer, Director | 15,000 | 2025-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings